ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.097,20
0,75%
S&P 500
5.945,68
1,34%
US Dollar vs BRL
6,0531
-1,61%
Bitcoin
97.050,60
-0,42%
Brent Oil
72,70
0,44%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) Notícias

MXCT

Maxcyte (MXCT)

Maxcyte Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:MXCT
DataHoraFonteTítuloCódigoCompanhia
19/12/202413:26RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/12/202409:29Alliance NewsAlliance NewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savingsLSE:MXCTMaxcyte Inc
09/12/202404:00RNS Regulatory NewsMaxCyte, Inc. MaxCyte Streamlines Operations and Raises GuidanceLSE:MXCTMaxcyte Inc
02/12/202414:09RNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
08/11/202411:41Alliance NewsAlliance NewsMaxCyte third-quarter profit falls amid surging costsLSE:MXCTMaxcyte Inc
07/11/202404:00RNS Regulatory NewsMaxCyte, Inc. Filing of 10Q formLSE:MXCTMaxcyte Inc
07/11/202404:00RNS Regulatory NewsMaxCyte, Inc. Third Quarter 2024 Financial ResultsLSE:MXCTMaxcyte Inc
06/11/202418:05UK RegulatoryMaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceLSE:MXCTMaxcyte Inc
06/11/202410:43RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
04/11/202410:23RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
31/10/202409:05RNS Non-RegulatoryMaxCyte, Inc. Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
18/10/202405:24RNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
15/10/202409:05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to BoardLSE:MXCTMaxcyte Inc
11/10/202409:00RNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
10/10/202409:05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCOLSE:MXCTMaxcyte Inc
16/09/202406:33Alliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
16/09/202403:00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
16/09/202403:00RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
06/09/202407:33RNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
07/08/202410:10Alliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
07/08/202403:05RNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
07/08/202403:00RNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
09/07/202405:14RNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
27/06/202410:34RNS Regulatory NewsMaxCyte, Inc. Publication of Annual ReportLSE:MXCTMaxcyte Inc
12/06/202403:00RNS Regulatory NewsMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
11/06/202407:10Alliance NewsAlliance NewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 sharesLSE:MXCTMaxcyte Inc
11/06/202403:00RNS Regulatory NewsMaxCyte, Inc. PDMR DealingLSE:MXCTMaxcyte Inc
29/05/202409:05RNS Regulatory NewsMaxCyte, Inc. Participation in Upcoming Investor ConferenceLSE:MXCTMaxcyte Inc
22/05/202417:51Alliance NewsAlliance NewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech supplyLSE:MXCTMaxcyte Inc
08/05/202405:46Alliance NewsAlliance NewsMaxCyte shares rise amid double-digit revenue increaseLSE:MXCTMaxcyte Inc
 Apresentando as notícias mais relevantes sobre:LSE:MXCT

Seu Histórico Recente

BIT
SELJLB
Selectra J Lamarck Biote...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados